This compound is a pharmaceutical intermediate featuring a purine nucleoside analog structure with a benzamide substituent and a methoxyethoxy side chain. It is primarily used in the manufacturing of nucleoside analog pharmaceuticals.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 333335-93-6
N6-BENZOYL-2'-O-METHYL-ADENOSINE
nucleoside intermediate for oligonucleotide synthesis
N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O-(2-methoxyethyl)Adenosine
pharmaceutical intermediate
Bz-2'-F-dA
research compound
N-Benzoyl-2'-O-(2-methoxyethyl)-5-methylcytidine
Pharmaceutical intermediate for nucleoside analogs
6-fluoro-7H-purin-2-amine
Pharmaceutical intermediate for nucleoside analogs
5-Methylcyclocytidine hydrochlorine
Pharmaceutical intermediate for nucleoside analogs
[(2S,3S,4S,5S)-3,4-diacetyloxy-5-(4,6-dichloroimidazo[4,5-c]pyridin-1-yl)oxolan-2-yl]methyl acetate
Pharmaceutical intermediate for nucleoside analogs
Fmoc-D-Lys(Dde)-OH
protected amino acid for peptide synthesis
N-[9-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-(2-methoxyethoxy)oxolan-2-yl]purin-6-yl]benzamide
RUFJMCSVNNGZFB-KHTYJDQRSA-N
COCCO[C@@H]1[C@@H]([C@H](O[C@H]1N2C=NC3=C(N=CN=C32)NC(=O)C4=CC=CC=C4)CO)O
—